Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yehuda Handelsman, Vivian Fonseca & Julio Rosenstock. (2012) Is combination therapy an effective way of reaching lipid goals in Type 2 diabetes mellitus?. Expert Review of Clinical Pharmacology 5:1, pages 43-54.
Read now
Read now
Nkechinyere Ijioma & Jennifer G Robinson. (2011) Lipid-lowering effects of ezetimibe and simvastatin in combination. Expert Review of Cardiovascular Therapy 9:2, pages 131-145.
Read now
Read now
Germán Gómez Briseño & Dolores Mino-León. (2010) Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico. Current Medical Research and Opinion 26:5, pages 1075-1081.
Read now
Read now
I. Migdalis, A. Efthimiadis, St. Pappas, D. Alexopoulos, F. Vlasserou & D. P. Mikhailidis. (2009) Clinical experience with ezetimibe/simvastatin in a Mediterranean population. Current Medical Research and Opinion 25:10, pages 2571-2576.
Read now
Read now
Steven K. Hildemann, Christian Barho, Barbara Karmann, Harald Darius & Christoph Bode. (2008) Sustained effects in hypercholesterolaemic patients on combined simvastatin/ezetimibe treatment: observational cohort study in clinical practice. Current Medical Research and Opinion 24:10, pages 2777-2784.
Read now
Read now
Steven Hildemann, Barbara Karmann, David Pittrow, Christian Barho, Harald Darius & Christoph Bode. (2008) Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care. Current Medical Research and Opinion 24:6, pages 1659-1668.
Read now
Read now
Jack S. Elder, Manan B. Shah, LaKeasha R. Batiste & Michael Eaddy. (2007) Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux. Current Medical Research and Opinion 23:sup4, pages S15-S20.
Read now
Read now
Articles from other publishers (16)
Jun Hwa Hong, Ung Jeon, Won-Yong Shin, Weon Kim, Kayeon Seong, Sang-Ho Park, Hee-dong Kim, Joong-Wha Chung & Jaehyuk Choi. (2022) A Paradigm Shift in Dyslipidemia Management in Primary Care: A 12-Month Cohort Study. Clinical Therapeutics 44:5, pages 698-709.
Crossref
Crossref
Parag Goyal, Leon I. Igel, Keith LaScalea & William B. Borden. (2014) Cardiometabolic Impact of Non-Statin Lipid Lowering Therapies. Current Atherosclerosis Reports 16:2.
Crossref
Crossref
Xianhai Huang & David Y.-K. Chen. (2012) A Case Study of Single-Pill Combination Therapy: The Ezetimibe/Simvastatin Combination for Treatment of Hyperlipidemia. ChemMedChem 7:11, pages 1882-1894.
Crossref
Crossref
Anselm K. Gitt, Claus Jünger, Christina Jannowitz, Barbara Karmann, Jochen Senges & Kurt Bestehorn. (2010) Adherence of hospital-based cardiologists to lipid guidelines in patients at high risk for cardiovascular events (2L registry). Clinical Research in Cardiology 100:4, pages 277-287.
Crossref
Crossref
Carlo M Rotella, Augusto Zaninelli, Cristina Le Grazie, Mary E Hanson & Gian Franco Gensini. (2010) Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes. Lipids in Health and Disease 9:1.
Crossref
Crossref
Anselm K. Gitt, Claus Juenger, Christina Jannowitz, Barbara Karmann, Juergen Senges & Kurt Bestehorn. (2009) Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry. European Journal of Cardiovascular Prevention & Rehabilitation 16:4, pages 438-444.
Crossref
Crossref
G. Derosa, A. D’Angelo, I. G. Franzetti, P. D. Ragonesi, G. Gadaleta, F. Scalise, L. Ciccarelli, M. N. Piccinni & A. F. G. Cicero. (2009) Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment. Journal of Clinical Pharmacy and Therapeutics 34:3, pages 267-276.
Crossref
Crossref
Manfredi Rizzo, Giovam Battista Rini, Giatgen A. Spinas & Kaspar Berneis. (2009) The effects of ezetimibe on LDL-cholesterol: Quantitative or qualitative changes?. Atherosclerosis 204:2, pages 330-333.
Crossref
Crossref
Tatjána Ábel, János Fehér, Elek Dinya, Mohamed Gamal Eldin & Attila Kovács. (2009) Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease. Orvosi Hetilap 150:21, pages 989-993.
Crossref
Crossref
Arshag D Mooradian. (2009) Dyslipidemia in type 2 diabetes mellitus. Nature Reviews Endocrinology 5:3, pages 150-159.
Crossref
Crossref
John Strony, Robert Hoffman, Mary Hanson & Enrico Veltri. (2008) Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: Results from two open-label extension studies in hypercholesterolemic patients. Clinical Therapeutics 30:12, pages 2280-2297.
Crossref
Crossref
Shin-ichiro Miura & Keijiro Saku. (2008) Beneficial effects of ezetimibe-based therapy in patients with dyslipidemia. Journal of Cardiology 52:1, pages 1-6.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:2, pages 193-219.
Crossref
Crossref
M. Florentin, E. N. Liberopoulos & M. S. Elisaf. (2007) Ezetimibe-associated adverse effects: what the clinician needs to know. International Journal of Clinical Practice 62:1, pages 88-96.
Crossref
Crossref
Susan J. Appel, Natalie A. Floyd & Emily J. Jones. (2007) Reducing Cardiovascular Risk and Managing Dyslipidemia in Women. Nursing for Women's Health 11:6, pages 586-599.
Crossref
Crossref
Michel Farnier. (2007) Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin. Fundamental & Clinical Pharmacology 21:s2, pages 27-28.
Crossref
Crossref